TVTX logo

Travere Therapeutics (TVTX) EV/EBITDA

EV/EBITDA

-7.22
0.000.00%

38 min ago


Summary


Performance

TVTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherTVTXvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

TVTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday0.0%+0.1%+0.1%
1 m1 month+14.7%-14.7%-18.5%
3 m3 months+2.7%-2.7%-5.1%
6 m6 months-74.8%+40.6%+36.7%
ytdytd-2.9%+2.9%+2.0%
1 y1 year-134.4%+90.9%+105.2%
5 y5 years+3.1%+140.4%+16.8%

TVTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-monthat high-9.42+23.4%
3 m3-month-6.81-6.0%-9.42+23.4%
6 m6-month-3.64-98.3%-9.42+23.4%
1 y1-year-2.11-242.2%-9.42+23.4%
3 y3-year-2.05-252.2%-13.46+46.4%
5 y5-year-2.05-252.2%-26.18+72.4%
alltimeall time181.49-104.0%-5339+99.9%

Travere Therapeutics EV/EBITDA History

DateValue
2025
-7.22(+2.8%)
2024
-7.02(+123.6%)
2023
-3.14(-60.4%)
2022
-7.93(-48.2%)
2021
-15.32(+40.4%)
2020
-10.91(+55.0%)
2019
-7.04(-50.8%)
DateValue
2018
-14.31(-29.9%)
2017
-20.40(+3.9%)
2016
-19.64(-450.7%)
2015
5.60(-130.3%)
2014
-18.48(+141.3%)
2013
-7.66(-99.7%)
2012
-2308.72

FAQ

  • What is Travere Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Travere Therapeutics?
  • What is TVTX EV/EBITDA year-to-date change?
  • What is Travere Therapeutics EV/EBITDA year-on-year change?

What is Travere Therapeutics EV/EBITDA?

The current EV/EBITDA of TVTX is -7.22

What is the all time high EV/EBITDA for Travere Therapeutics?

Travere Therapeutics all-time high EV/EBITDA is 181.49

What is TVTX EV/EBITDA year-to-date change?

Travere Therapeutics EV/EBITDA has changed by -0.20 (-2.85%) since the beginning of the year

What is Travere Therapeutics EV/EBITDA year-on-year change?

Over the past year, TVTX EV/EBITDA has changed by -4.14 (-134.42%)